Megestrol Acetate Dispersible Tablets Application Scope

Megestrol Acetate Dispersible Tablets are used for the palliative treatment of hormone-dependent patients with advanced endometrial and breast cancer.

megestrol acetate dispersible tablets

Features of Megestrol Acetate Dispersible Tablets

Characteristics: advanced endometrial cancer and breast cancer

Specification: 160mg

Packing specification: 10*160mg

Storage: Shielded from light, airtight storage.

Effective period: 36 months

Execution Standard: Chinese Pharmacopoeia, 2010 Edition, Part II.

Approval number: China Pharmacopoeia H20010074

Revision Date According to the latest drug instruction.

Manufacturer: Guohai Biopharmaceutical

Medroxyprogesterone Acetate Dispersible Tablets Directions for Use

Dosage and administration: Normal dose: 160mg (one tablet) each time, taken orally once daily. High dose: 160mg (one tablet) each time, orally, 2-4 times daily.
ADVERSE REACTIONS: Adrenocortisol effects, full moon face, hypertension, hyperglycemia. The incidence of uterine bleeding is 1-2%. Occasional nausea and vomiting, rare dyspnea, heart failure, rash.

Medication restrictions for Megestrol Acetate Dispersible Tablets

Contraindication: It is forbidden for those who are allergic to this product. Contraindicated in patients with severe thrombophlebitis, thromboembolic disease, severe hepatic impairment and hypercalcemia due to bone metastasis.

Precautions: Close monitoring should be routinely performed on patients treated with this product, and it should be used with caution in patients with uncontrolled diabetes mellitus and hypertension. It is not advocated for use in the postoperative adjuvant treatment of breast cancer. Contraindicated for use in pregnancy diagnostic tests.

Megestrol Acetate Dispersible Tablets Interactions

Interactions of Megestrol Acetate Dispersible Tablets with other drugs have not been determined. Before starting treatment, inform your doctor of all medications you are using.

Note: If there is a new packaging for the drug, the new packaging shall prevail. The above information is sourced from DengYueMedicine, China Medicine Wholesaler. It is only for internal discussion among medical staff and does not serve as a basis for medication. For specific medication guidelines, please consult the attending physician.